Autologous apoptotic cell engulfment stimulates chemokine secretion by vascular smooth muscle cells

American Journal of Pathology

Volumn 167, Issue 2, 2005, Pages 345-353

  Fries, Diana M ^a,b   Lightfoot, Richard ^a   Koval, Michael ^c   Ischiropoulos, Harry ^a,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b MINISTÉRIO DA SAÚDE   (Brazil)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; ELASTIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD VESSEL INJURY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLOGY; ELECTRON MICROSCOPY; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; INFLAMMATION; INTERNALIZATION; LYSOSOME; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; ANIMAL; AORTA; CELL CULTURE; CELL SURVIVAL; CONFOCAL MICROSCOPY; IMMUNOELECTRON MICROSCOPY; INJURY; METABOLISM; SECRETION; SPRAGUE DAWLEY RAT;

ANIMALS; AORTA; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINES; ELASTIN; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, IMMUNOELECTRON; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; WOUNDS AND INJURIES;

EID: 25144442811     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62980-X     Document Type: Article

References (39)

1. Bennett MR, Evan GI, Schwartz SM: Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995, 95:2266-2274
2. Han DK, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G: Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995, 147:267-277
3. Geng YJ, Libby P: Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 1995, 147:251-266
4. Devlin AM, Clark JS, Reid JL, Dominiczak AF: DNA synthesis and apoptosis in smooth muscle cells from a model of genetic hypertension. Hypertension 2000, 36:110-115
5. Bennett MR, Evan GI, Schwartz SM: Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ Res 1995, 77:266-273
6. Boyle JJ, Weissberg PL, Bennett MR: Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb Vasc BiOl 2003, 23:1553-1558
7. Loidl A, Sevcsik E, Riesenhuber G, Deigner HP, Hermetter A: Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells. J Biol Chem 2003, 278:32921-32928
8. Sandberg EM, Sayeski PP: Jak2 tyrosine kinase mediates oxidative stress-induced apoptosis in vascular smooth muscle cells. J Biol Chem 2004, 279:34547-34552
9. Savill J, Fadok V: Corpse clearance defines the meaning of cell death. Nature 2000, 407:784-788
10. Gregory CD: CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr Opin Immunol 2000, 12:27-34
11. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM: A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000, 405:85-90
12. Li MO, Sarkisian WIR, Mehal WZ, Rakic P, Flavell RA: Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 2003, 302:1560-1563
13. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S: Identification of a factor that links apoptotic cells to phagocytes. Nature 2002, 417:182-187
14. Garfield RE, Chacko S, Blose S: Phagocytosis by muscle cells. Lab Invest 1975, 33:418-427
15. Bennett MR, Gibson DF. Schwartz SM, Tait JF: Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res 1995, 77:1136-1142
16. Decorti G, Klugmann FB, Crivellato E, Malusa N, Furlan G, Candussio L, Giraidi T: Biochemical and microscopic evidence for the internalization of drug-containing mast cell granules by macrophages and smooth muscle cells. Toxicol Appl Pharmacol 2000, 169:269-275
17. Kockx MM, Herman AG: Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 2000, 45:736-746
18. Kockx MM, Cromheeke KM, Knaapen MW, Bosmans JM, De Meyer GR, Herman AG, Bult H: Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 2003, 23:440-446
19. Tabas I: Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Cell Death Differ 2004, 11:312-316
20. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK: p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II: role in vascular smooth muscle cell hypertrophy. J Biol Chem 1998, 273:15022-15029
21. Fries DM, Paxinou E, Themistocleous M, Swanberg E, Griendling KK, Salvemini D, Slot JW, Heijnen HFG, Hazen SL, Ischiropoulos H: Expression of inducible nitric oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells: role of reactive oxygen species. J Biol Chem 2003, 278:22901-22907
22. Sukhova GK, Shi G-P, Simon DI, Chapman HA, Libby P: Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998, 102:576-583
23. 14C] elastin as a substrate for assaying elastolytic enzyme in cellular and tissue extracts. Biochem Med 1979, 21:108-120
24. Waf1 and p27kip1. Circulation 2000, 102:2124-2130
25. Ohkuma S, Poole B: Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci USA 1978, 75:3327-3331
26. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998, 101:890-898
27. Monks J, Rosner D, Geske FJ, Lehman L, Hanson L, Neville MC, Fadok VA: Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ 2005, 12:107-114
28. Golpon HA, Fadok VA, Taraseviciene-Steward L, Scerbavicius R, Sauer C, Welte T, Hensons PM, Voelkel NF: Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J 2004, 18:1716-1718
29. Nelken NA, Coughlin SR, Gordon D, Wilcox JN: Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991, 88:1121-1127
30. Koch AE, Kunkel SL, Pearce WH, Shah MR, Parikh D, Evanoff HL, Haines GK, Burdick MD, Strieter RM: Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am J Pathol 1993, 142:1423-1431
31. Reckless J, Rubin EM, Verstuyft JB, Metcalfe JC, Grainger DJ: Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesions. Circulation 1999, 99:2310-2316
32. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, Rosenzweig A: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398:718-723
33. Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA: A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 1998, 101:353-363
34. Schaub FJ, Han DK, Liles WC, Adams LD, Coats SA, Ramachandran RK, Seifert RA, Schwartz SM, Bowen-Pope DF: Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat Med 2000, 6:790-796
35. Boring L, Gosling J, Cleary M, Charo IF: Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394:894-897
36. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ: Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998, 2:275-281
37. Proudfoot D, Davies JD, Skepper JN, Weissberg PL, Shanahan CM: Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation 2002, 106:3044-3050
38. Khan M, Pelengaris S, Cooper M, Smith C, Evan G, Betteridge J: Oxidised lipoproteins may promote inflammation through the selective delay of engulfment but not binding of apoptotic cells by macrophages. Atherosclerosis 2003, 171:21-29
39. Anderson HA, Englert R, Gursel I, Shacter E: Oxidative stress inhibits the phagocytosis of apoptotic cells that have externalized phosphatidylserine. Cell Death Differ 2002, 9:616-625